| AGEs | Advanced Glycation End-products |
| BMI | Body Mass Index |
| CI | Confidence Interval |
| CMIE | Continuous Moderate-Intensity Exercise |
| CRP | C-Reactive Protein |
| CVD | Cardiovascular Disease |
| GLUT4 | Glucose Transporter Type 4 |
| HDL-c | High-Density Lipoprotein Cholesterol |
| HIIT | High-Intensity Interval Training |
| HIIE | High-Intensity Interval Exercise |
| HRmax | Maximum Heart Rate |
| IL-6 | Interleukin-6 |
| IL-10 | Interleukin-10 |
| MICT | Moderate-Intensity Continuous Training |
| NAFLD | Non-Alcoholic Fatty Liver Disease |
| NF-κB | Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells |
| NPY | Neuropeptide Y |
| PI3K/Akt | Phosphoinositide 3-Kinase/Protein Kinase B |
| PTX3 | Pentraxin-3 |
| RCT | Randomized Controlled Trial |
| RM | Repetition Maximum |
| T2D | Type 2 Diabetes |
| TLR2/4 | Toll-Like Receptor 2/4 |
| TNF-α | Tumor Necrosis Factor-Alpha |
| VO2max | Maximal Oxygen Uptake |
| Wmax | Maximum Workload |